-
Je něco špatně v tomto záznamu ?
Decoding the historical tale: COVID-19 impact on haematological malignancy patients-EPICOVIDEHA insights from 2020 to 2022
J. Salmanton-García, F. Marchesi, F. Farina, B. Weinbergerová, F. Itri, J. Dávila-Valls, S. Martín-Pérez, A. Glenthøj, DS. Hersby, M. Gomes da Silva, R. Nunes Rodrigues, A. López-García, R. Córdoba, YM. Bilgin, I. Falces-Romero, S. El-Ashwah, Z....
Status neindexováno Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články
NLK
Directory of Open Access Journals
od 2018
PubMed Central
od 2018
Europe PubMed Central
od 2018
ROAD: Directory of Open Access Scholarly Resources
od 2018
- Publikační typ
- časopisecké články MeSH
BACKGROUND: The COVID-19 pandemic heightened risks for individuals with hematological malignancies due to compromised immune systems, leading to more severe outcomes and increased mortality. While interventions like vaccines, targeted antivirals, and monoclonal antibodies have been effective for the general population, their benefits for these patients may not be as pronounced. METHODS: The EPICOVIDEHA registry (National Clinical Trials Identifier, NCT04733729) gathers COVID-19 data from hematological malignancy patients since the pandemic's start worldwide. It spans various global locations, allowing comprehensive analysis over the first three years (2020-2022). FINDINGS: The EPICOVIDEHA registry collected data from January 2020 to December 2022, involving 8767 COVID-19 cases in hematological malignancy patients from 152 centers across 41 countries, with 42% being female. Over this period, there was a significant reduction in critical infections and an overall decrease in mortality from 29% to 4%. However, hospitalization, particularly in the ICU, remained associated with higher mortality rates. Factors contributing to increased mortality included age, multiple comorbidities, active malignancy at COVID-19 onset, pulmonary symptoms, and hospitalization. On the positive side, vaccination with one to two doses or three or more doses, as well as encountering COVID-19 in 2022, were associated with improved survival. INTERPRETATION: Patients with hematological malignancies still face elevated risks, despite reductions in critical infections and overall mortality rates over time. Hospitalization, especially in ICUs, remains a significant concern. The study underscores the importance of vaccination and the timing of COVID-19 exposure in 2022 for enhanced survival in this patient group. Ongoing monitoring and targeted interventions are essential to support this vulnerable population, emphasizing the critical role of timely diagnosis and prompt treatment in preventing severe COVID-19 cases. FUNDING: Not applicable.
Aga Khan University Karachi Pakistan
Amsterdam UMC Location VUmc Amsterdam Netherlands
Ankara University Ankara Turkey
AOU Policlinico Rodolico San Marco Catania Italy
Aseer Central Hospital Abha Saudi Arabia
ASST Grande Ospedale Metropolitano Niguarda Milan Italy
Azienda Ospedaliera Ospedali Riuniti Villa Sofia Cervello Palermo Italy
Azienda Ospedaliera San Gerardo Monza Monza Italy
Azienda Ospedaliera Sant'Anna e San Sebastiano Caserta Italy
Azienda Sanitaria Universitaria del Friuli Centrale Udine Italy
Center for Radiology University Clinical Center of Serbia Belgrade Serbia
Centre Hospitalier de Versailles Le Chesnay France
Centro Hospitalar e Universitário São João Porto Portugal
CIBERINFEC Instituto de Salud Carlos 3 Madrid Spain
Cipto Mangunkusumo General Hospital Jakarta Indonesia
Comenius University and National Cancer Institute Bratislava Slovakia
COVID Hospital Batajnica Belgrade Serbia
CRA from CRC Centre Hospitalier Victor DUPOUY Argenteuil France
Croatian Cooperative Group for Hematological Diseases Croatia
Department of Hematology and Oncology Comprehensive Cancer Center Innsbruck Innsbruck Austria
Department of Hematology CH Sud Francilien Corbeil Essonnes France
Department of Hematology Copenhagen University Hospital Rigshospitalet Copenhagen Denmark
Department of Hematology Hospital Universitario de Burgos Burgos Spain
Department of Hematology Research Unit Hospital Universitario de Burgos Burgos Spain
Department of Infectious Diseases Karolinska University Hospital Stockholm Sweden
Department of Internal Medicine ADRZ Goes Netherlands
Department of Mental Health and Public Medicine University of Campania Naples Italy
Department of Nephrology and Infectious diseases AZ Sint Jan Brugge Oostende AV Brugge Belgium
Department of Physiology Faculty of Medicine Masaryk University Brno Czech Republic
Division of Hematology Department of Internal Medicine University of Debrecen Debrecen Hungary
Dokuz Eylul University Division of Hematology Izmir Turkey
Ematologia con Trapianto Ospedale Dimiccoli Barletta Barletta Italy
Faculty of Medicine and Faculty of Health Studies of University of Rijeka Rijeka Croatia
Faculty of Medicine University of Zagreb Zagreb Croatia
Fundación Jimenez Diaz University Hospital Health Research Institute IIS FJD Madrid Spain
General Hospital of Thessaloniki George Papanikolaou Thessaloniki Greece
German Centre for Infection Research Partner Site Bonn Cologne Cologne Germany
Gomel State Medical University Gomel Belarus
Hamad Medical Corporation Doha Qatar
Head ICU and CRC Centre Hospitalier Victor DUPOUY Argenteuil France
Hematology and Stem Cell Transplant Unit IRCCS Regina Elena National Cancer Institute Rome Italy
Hematology and Stem Cell Transplant Unit Osperadiela University Pisana Company Pisa Italy
Hematology and Stem Cell Transplantation Unit AOUC Policlinico Bari Italy
Hematology Department of Biomedicine and Prevention University of Rome Tor Vergata Rome Italy
Hematology Unit ASST Spedali Civili Brescia Italy
Hematology Unit Center for Translational Medicine Azienda USL Toscana NordOvest Livorno Italy
Hematology Unit Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Milan Italy
Hematology Unit Fondazione Policlinico Universitario Agostino Gemelli IRCCS Rome Italy
Hematology Unit Università Cattolica del Sacro Cuore Rome Italy
Hopital Saint Louis Paris France
Hospital Escuela de Agudos Dr Ramón Madariaga Posadas Argentina
Hospital Nuestra Señora de Sonsoles Ávila Spain
Hospital Rey Juan Carlos Móstoles Spain
Hospital Universitario 12 de Octubre Madrid Spain
Hospital Universitario de Cabueñes Gijón Spain
Hospital Universitario de Navarra Iruña Pamplona Spain
Hospital Universitario de Salamanca Salamanca Spain
Hospital Universitario Infanta Leonor Madrid Spain
Hospital Universitario Lucus Augusti Lugo Spain
Hospital Universitario Marqués de Valdecilla Santander Spain
Hospital Universitario Puerta de Hierro Majadahonda Spain
Hospital Universitario Virgen del Puerto Plasencia Spain
Hospital University of Parma Hematology and Bone Marrow Unit Parma Italy
Institute of Hematology and Blood Transfusion Prague Czech Republic
Instituto Nacional do Cancer Rio de Janeiro Brazil
IRCCS Ospedale San Raffaele Milan Italy
Istituto Oncologico della Svizzera Italiana Bellinzona Switzerland
King Abdullah Medical City Makkah Saudi Arabia
Laikon Hospital Medical School National and Kapodistrian University of Athens Athens Greece
Medical University of Graz Graz Austria
Medizinische Klinik 2 Klinikum Rechts der Isar TU München Munich Germany
Microbiology and Parasitology Department University Hospital La Paz Madrid Spain
Necker Enfants Malades Hospitals Paris France
North Western State Medical University Named after Iliá Ilich Méchnikov Saint Petersburg Russia
Northumbria Healthcare Newcastle United Kingdom
Oncology Center Mansoura University Mansoura Egypt
Ospedale Policlinico San Martino Genoa Italy
Ospedale Vito Fazzi Lecce Italy
Oxford University Hospitals Oxford United Kingdom
Policlinico Borgo Roma Verona Verona Italy
Portuguese Institute of Oncology Lisbon Portugal
San Bortolo Hospital Vicenza Italy
San Luigi Gonzaga Hospital Orbassano Orbassano Italy
Sapienza University of Rome Rome Italy
Shaukat Khanum Memorial Cancer Hospital and Research Centre Lahore Pakistan
Stem Cell Transplant Center AOU Citta' della Salute e della Scienza Turin Italy
Sultan Qaboos University Hospital Muscat Oman
Università Milano Bicocca Milan Italy
Universitätsklinikum Frankfurt am Main Frankfurt am Main Germany
Université Paris Saclay UVSQ Inserm Équipe Exposome et Hérédité CESP Villejuif France
University Clinic of Hematology Skopje North Macedonia
University Clinical Center of Serbia Belgrade Serbia
University Clinical Center Serbia Belgrade Serbia
University Hospital Centre Rijeka Rijeka Croatia
University Hospital Centre Zagreb Zagreb Croatia
University Hospital Dubrava Zagreb Croatia
University Hospital Hradec Králové Hradec Králové Czech Republic
University Hospital of Basel Basel Switzerland
University Hospital of Královské Vinohrady Prague Czech Republic
University Hospital Olomouc Olomouc Czech Republic
University Hospital Ostrava Ostrava Czech Republic
University Hospital Pilsen Pilsen Czech Republic
University Medical Center Groningen Groningen Netherlands
University Medical Center Hamburg Eppendorf Hamburg Germany
University of Kansas Medical Center Kansas City United States
University of Milan and Fondazione IRCCS Istituto Nazionale Dei Tumori Milan Italy
UOC Hematology AORN Cardarelli Naples Italy
Weill Cornell Medicine New York United States
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24005503
- 003
- CZ-PrNML
- 005
- 20240412130955.0
- 007
- ta
- 008
- 240405e20240318enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.eclinm.2024.102553 $2 doi
- 035 __
- $a (PubMed)38533127
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Salmanton-García, Jon $u University of Cologne, Faculty of Medicine, and University Hospital Cologne, Institute of Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, Germany $u University of Cologne, Faculty of Medicine, University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) and Excellence Center for Medical Mycology (ECMM), Cologne, Germany $u German Centre for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany
- 245 10
- $a Decoding the historical tale: COVID-19 impact on haematological malignancy patients-EPICOVIDEHA insights from 2020 to 2022 / $c J. Salmanton-García, F. Marchesi, F. Farina, B. Weinbergerová, F. Itri, J. Dávila-Valls, S. Martín-Pérez, A. Glenthøj, DS. Hersby, M. Gomes da Silva, R. Nunes Rodrigues, A. López-García, R. Córdoba, YM. Bilgin, I. Falces-Romero, S. El-Ashwah, Z. Emarah, C. Besson, M. Kohn, J. Van Doesum, E. Ammatuna, M. Marchetti, J. Labrador, GPM. Zambrotta, L. Verga, O. Jaksic, M. Nucci, K. Piukovics, A. Cabirta-Touzón, M. Jiménez, E. Arellano, I. Espigado, O. Blennow, A. Nordlander, S. Meers, J. van Praet, TF. Aiello, C. Garcia-Vidal, N. Fracchiolla, M. Sciumè, GC. Seval, P. Žák, C. Buquicchio, C. Tascini, SK. Gräfe, M. Schönlein, T. Adžić-Vukičević, V. Bonuomo, C. Cattaneo, S. Nizamuddin, M. Čerňan, G. Plantefeve, R. Prin, T. Szotkovski, GP. Collins, M. Dargenio, V. Petzer, D. Wolf, N. Čolović, L. Prezioso, T. Valković, F. Passamonti, GA. Méndez, U. Sili, A. Vena, M. Bavastro, A. Limongelli, RF. Duarte, MP. Ledoux, M. Cvetanoski, Z. Stojanoski, M. Machado, J. Batinić, G. Magliano, MM. Biernat, N. Pantić, CB. Poulsen, A. Cuccaro, MI. Del Principe, A. Kulasekararaj, I. Ormazabal-Vélez, A. Busca, F. Demirkan, M. Ijaz, N. Klimko, I. Stoma, S. Khostelidi, N. Fernández, AS. Omrani, R. Bergantim, N. De Jonge, G. Fouquet, M. Navrátil, G. Abu-Zeinah, M. Samarkos, J. Maertens, C. De Ramón, A. Guidetti, F. Magyari, TJ. González-López, T. Lahmer, O. Finizio, N. Ali, LI. Pinczés, E. Lavilla-Rubira, A. Romano, M. Merelli, M. Delia, M. Calbacho, J. Meletiadis, D. Antić, JÁ. Hernández-Rivas, J. Marques de Almeida, M. Al-Khabori, M. Hoenigl, MC. Tisi, N. Khanna, A. Barać, N. Eisa, R. Di Blasi, R. Liévin, C. Miranda-Castillo, NC. Bahr, S. Lamure, MV. Papa, A. Yahya, A. Aujayeb, J. Novák, N. Erben, M. Fernández-Galán, JM. Ribera-Santa Susana, I. Rinaldi, R. Fazzi, M. Piedimonte, R. Duléry, Y. Gonzaga, A. Soto-Silva, G. Sapienza, A. Serris, Ľ. Drgoňa, A. Groh, L. Serrano, E. Gavriilaki, A. Tragiannidis, J. Prattes, N. Coppola, V. Otašević, M. Mladenović, M. Mitrović, B. Mišković, P. Jindra, S. Zompi, MV. Sacchi, C. Krekeler, MS. Infante, D. García-Bordallo, GM. Çolak, J. Mayer, M. Nygaard, M. Hanáková, Z. Ráčil, M. Bonanni, P. Koehler, L. Rahimli, OA. Cornely, L. Pagano, EPICOVIDEHA registry
- 520 9_
- $a BACKGROUND: The COVID-19 pandemic heightened risks for individuals with hematological malignancies due to compromised immune systems, leading to more severe outcomes and increased mortality. While interventions like vaccines, targeted antivirals, and monoclonal antibodies have been effective for the general population, their benefits for these patients may not be as pronounced. METHODS: The EPICOVIDEHA registry (National Clinical Trials Identifier, NCT04733729) gathers COVID-19 data from hematological malignancy patients since the pandemic's start worldwide. It spans various global locations, allowing comprehensive analysis over the first three years (2020-2022). FINDINGS: The EPICOVIDEHA registry collected data from January 2020 to December 2022, involving 8767 COVID-19 cases in hematological malignancy patients from 152 centers across 41 countries, with 42% being female. Over this period, there was a significant reduction in critical infections and an overall decrease in mortality from 29% to 4%. However, hospitalization, particularly in the ICU, remained associated with higher mortality rates. Factors contributing to increased mortality included age, multiple comorbidities, active malignancy at COVID-19 onset, pulmonary symptoms, and hospitalization. On the positive side, vaccination with one to two doses or three or more doses, as well as encountering COVID-19 in 2022, were associated with improved survival. INTERPRETATION: Patients with hematological malignancies still face elevated risks, despite reductions in critical infections and overall mortality rates over time. Hospitalization, especially in ICUs, remains a significant concern. The study underscores the importance of vaccination and the timing of COVID-19 exposure in 2022 for enhanced survival in this patient group. Ongoing monitoring and targeted interventions are essential to support this vulnerable population, emphasizing the critical role of timely diagnosis and prompt treatment in preventing severe COVID-19 cases. FUNDING: Not applicable.
- 590 __
- $a NEINDEXOVÁNO
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Marchesi, Francesco $u Hematology and Stem Cell Transplant Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy
- 700 1_
- $a Farina, Francesca $u IRCCS Ospedale San Raffaele, Milan, Italy
- 700 1_
- $a Weinbergerová, Barbora $u Masaryk University and University Hospital Brno - Department of Internal Medicine, Hematology and Oncology, Brno, Czech Republic
- 700 1_
- $a Itri, Federico $u San Luigi Gonzaga Hospital - Orbassano, Orbassano, Italy
- 700 1_
- $a Dávila-Valls, Julio $u Hospital Nuestra Señora de Sonsoles, Ávila, Spain
- 700 1_
- $a Martín-Pérez, Sonia $u Hospital Nuestra Señora de Sonsoles, Ávila, Spain
- 700 1_
- $a Glenthøj, Andreas $u Department of Hematology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark
- 700 1_
- $a Hersby, Ditte Stampe $u Department of Hematology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark
- 700 1_
- $a Gomes da Silva, Maria $u Portuguese Institute of Oncology, Lisbon, Portugal
- 700 1_
- $a Nunes Rodrigues, Raquel $u Portuguese Institute of Oncology, Lisbon, Portugal
- 700 1_
- $a López-García, Alberto $u Fundación Jimenez Diaz University Hospital, Health Research Institute IIS-FJD, Madrid, Spain
- 700 1_
- $a Córdoba, Raúl $u Fundación Jimenez Diaz University Hospital, Health Research Institute IIS-FJD, Madrid, Spain
- 700 1_
- $a Bilgin, Yavuz M $u Department of Internal Medicine, ADRZ, Goes, Netherlands
- 700 1_
- $a Falces-Romero, Iker $u Microbiology and Parasitology Department, University Hospital La Paz, Madrid, Spain $u CIBERINFEC, Instituto de Salud Carlos III, Madrid, Spain
- 700 1_
- $a El-Ashwah, Shaimaa $u Oncology Center, Mansoura University, Mansoura, Egypt
- 700 1_
- $a Emarah, Ziad $u Oncology Center, Mansoura University, Mansoura, Egypt $u King Abdullah Medical City, Makkah, Saudi Arabia
- 700 1_
- $a Besson, Caroline $u Centre Hospitalier de Versailles, Le Chesnay, France $u Université Paris-Saclay, UVSQ, Inserm, Équipe "Exposome et Hérédité", CESP, Villejuif, France
- 700 1_
- $a Kohn, Milena $u Centre Hospitalier de Versailles, Le Chesnay, France $u Université Paris-Saclay, UVSQ, Inserm, Équipe "Exposome et Hérédité", CESP, Villejuif, France
- 700 1_
- $a Van Doesum, Jaap $u University Medical Center Groningen, Groningen, Netherlands
- 700 1_
- $a Ammatuna, Emanuele $u University Medical Center Groningen, Groningen, Netherlands
- 700 1_
- $a Marchetti, Monia $u Hematology and Transplant Unit, Azienda Ospedaliera SS Antonio e Biagio e Cesare Arrigo, Alessandria, Italy
- 700 1_
- $a Labrador, Jorge $u Department of Hematology, Research Unit, Hospital Universitario de Burgos, Burgos, Spain
- 700 1_
- $a Zambrotta, Giovanni Paolo Maria $u Azienda Ospedaliera San Gerardo - Monza, Monza, Italy $u Università Milano-Bicocca, Milan, Italy
- 700 1_
- $a Verga, Luisa $u Azienda Ospedaliera San Gerardo - Monza, Monza, Italy $u Università Milano-Bicocca, Milan, Italy
- 700 1_
- $a Jaksic, Ozren $u University Hospital Dubrava, Zagreb, Croatia
- 700 1_
- $a Nucci, Marcio $u Department of Internal Medicine, Federal University of Rio de Janeiro and Grupo Oncoclinicas, Rio de Janeiro, Brazil
- 700 1_
- $a Piukovics, Klára $u Department of Internal Medicine, South Division Faculty of Medicine University of Szeged, Szeged, Hungary
- 700 1_
- $a Cabirta-Touzón, Alba $u Department of Hematology, Vall d'Hebron Hospital Universitari, Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain
- 700 1_
- $a Jiménez, Moraima $u Department of Hematology, Vall d'Hebron Hospital Universitari, Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain
- 700 1_
- $a Arellano, Elena $u Department of Hematology, University Hospital Virgen Macarena - University Hospital Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBIS/CSIC), Universidad de Sevilla (Departamento de Medicina), Seville, Spain
- 700 1_
- $a Espigado, Ildefonso $u Department of Hematology, University Hospital Virgen Macarena - University Hospital Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBIS/CSIC), Universidad de Sevilla (Departamento de Medicina), Seville, Spain
- 700 1_
- $a Blennow, Ola $u Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden
- 700 1_
- $a Nordlander, Anna $u Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden
- 700 1_
- $a Meers, Stef $u AZ KLINA, Brasschaat, Belgium
- 700 1_
- $a van Praet, Jens $u Department of Nephrology and Infectious diseases, AZ Sint-Jan Brugge-Oostende AV, Brugge, Belgium
- 700 1_
- $a Aiello, Tommaso Francesco $u Department of Infectious Diseases, Hospital Clinic de Barcelona, University of Barcelona, IDIBAPS, Barcelona, Spain
- 700 1_
- $a Garcia-Vidal, Carolina $u Department of Infectious Diseases, Hospital Clinic de Barcelona, University of Barcelona, IDIBAPS, Barcelona, Spain
- 700 1_
- $a Fracchiolla, Nicola $u Hematology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy
- 700 1_
- $a Sciumè, Mariarita $u Hematology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy
- 700 1_
- $a Seval, Guldane Cengiz $u Ankara University, Ankara, Turkey
- 700 1_
- $a Žák, Pavel $u University Hospital Hradec Králové, Hradec Králové, Czech Republic
- 700 1_
- $a Buquicchio, Caterina $u Ematologia con Trapianto, Ospedale Dimiccoli Barletta, Barletta, Italy
- 700 1_
- $a Tascini, Carlo $u Azienda Sanitaria Universitaria del Friuli Centrale, Udine, Italy
- 700 1_
- $a Gräfe, Stefanie K $u University Medical Center Hamburg-Eppendorf, Hamburg, Germany
- 700 1_
- $a Schönlein, Martin $u Department of Oncology, Hematology and Bone Marrow Transplantation with Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
- 700 1_
- $a Adžić-Vukičević, Tatjana $u COVID Hospital "Batajnica", Belgrade, Serbia
- 700 1_
- $a Bonuomo, Valentina $u Policlinico Borgo Roma Verona, Verona, Italy
- 700 1_
- $a Cattaneo, Chiara $u Hematology Unit, ASST-Spedali Civili, Brescia, Italy
- 700 1_
- $a Nizamuddin, Summiya $u Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan
- 700 1_
- $a Čerňan, Martin $u University Hospital Olomouc, Olomouc, Czech Republic
- 700 1_
- $a Plantefeve, Gaëtan $u Head ICU and CRC, Centre Hospitalier Victor DUPOUY, Argenteuil, France
- 700 1_
- $a Prin, Romane $u CRA from CRC Centre Hospitalier Victor DUPOUY, Argenteuil, France
- 700 1_
- $a Szotkovski, Tomas $u University Hospital Olomouc, Olomouc, Czech Republic
- 700 1_
- $a Collins, Graham P $u Oxford University Hospitals, Oxford, United Kingdom
- 700 1_
- $a Dargenio, Michelina $u Ospedale Vito Fazzi, Lecce, Italy
- 700 1_
- $a Petzer, Verena $u Department of Hematology and Oncology, Comprehensive Cancer Center Innsbruck (CCCI), Medical University of Innsbruck (MUI), Innsbruck, Austria
- 700 1_
- $a Wolf, Dominik $u Department of Hematology and Oncology, Comprehensive Cancer Center Innsbruck (CCCI), Medical University of Innsbruck (MUI), Innsbruck, Austria
- 700 1_
- $a Čolović, Natasha $u University Clinical Center Serbia, Belgrade, Serbia
- 700 1_
- $a Prezioso, Lucia $u Hospital University of Parma - Hematology and Bone Marrow Unit, Parma, Italy
- 700 1_
- $a Valković, Toni $u University Hospital Centre Rijeka, Rijeka, Croatia $u Croatian Cooperative Group for Hematological Diseases (CROHEM), Croatia $u Faculty of Medicine and Faculty of Health Studies of University of Rijeka, Rijeka, Croatia
- 700 1_
- $a Passamonti, Francesco $u Department of Medicine and Surgery, University of Insubria and ASST Sette Laghi, Ospedale di Circolo of Varese, Varese, Italy
- 700 1_
- $a Méndez, Gustavo-Adolfo $u Hospital Escuela de Agudos Dr. Ramón Madariaga, Posadas, Argentina
- 700 1_
- $a Sili, Uluhan $u Department of Infectious Diseases and Clinical Microbiology, School of Medicine, Marmara University, Istanbul, Turkey
- 700 1_
- $a Vena, Antonio $u Ospedale Policlinico San Martino, Genoa, Italy
- 700 1_
- $a Bavastro, Martina $u Ospedale Policlinico San Martino, Genoa, Italy
- 700 1_
- $a Limongelli, Alessandro $u Ospedale Policlinico San Martino, Genoa, Italy
- 700 1_
- $a Duarte, Rafael F $u Hospital Universitario Puerta de Hierro, Majadahonda, Spain
- 700 1_
- $a Ledoux, Marie-Pierre $u ICANS, Strasbourg, France
- 700 1_
- $a Cvetanoski, Milche $u University Clinic of Hematology, Skopje, North Macedonia
- 700 1_
- $a Stojanoski, Zlate $u University Clinic of Hematology, Skopje, North Macedonia
- 700 1_
- $a Machado, Marina $u Clinical Microbiology and Infectious Diseases Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain
- 700 1_
- $a Batinić, Josip $u Croatian Cooperative Group for Hematological Diseases (CROHEM), Croatia $u University Hospital Centre Zagreb, Zagreb, Croatia $u Faculty of Medicine University of Zagreb, Zagreb, Croatia
- 700 1_
- $a Magliano, Gabriele $u ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy
- 700 1_
- $a Biernat, Monika M $u Wroclaw Medical University, Wroclaw, Poland
- 700 1_
- $a Pantić, Nikola $u University Clinical Center of Serbia, Belgrade, Serbia
- 700 1_
- $a Poulsen, Christian Bjørn $u Zealand University Hospital, Roskilde, Denmark
- 700 1_
- $a Cuccaro, Annarosa $u Hematology Unit, Center for Translational Medicine, Azienda USL Toscana NordOvest, Livorno, Italy $u National Cancer Institute, Fondazione 'G. Pascale', IRCCS, Hematology-Oncology and Stem Cell Transplantation Unit, Naples, Italy
- 700 1_
- $a Del Principe, Maria Ilaria $u Hematology, Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy
- 700 1_
- $a Kulasekararaj, Austin $u Department of Hematological Medicine, King's College Hospital NHS Foundation Trust, London, United Kingdom
- 700 1_
- $a Ormazabal-Vélez, Irati $u Hospital Universitario de Navarra, Iruña-Pamplona, Spain
- 700 1_
- $a Busca, Alessandro $u Stem Cell Transplant Center, AOU Citta' della Salute e della Scienza, Turin, Italy
- 700 1_
- $a Demirkan, Fatih $u Dokuz Eylul University, Division of Hematology, Izmir, Turkey
- 700 1_
- $a Ijaz, Marriyam $u Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan
- 700 1_
- $a Klimko, Nikolai $u North-Western State Medical University Named after Iliá Ilich Méchnikov, Saint-Petersburg, Russia
- 700 1_
- $a Stoma, Igor $u Gomel State Medical University, Gomel, Belarus
- 700 1_
- $a Khostelidi, Sofya $u North-Western State Medical University Named after Iliá Ilich Méchnikov, Saint-Petersburg, Russia
- 700 1_
- $a Fernández, Noemí $u Hospital Universitario Marqués de Valdecilla, Santander, Spain
- 700 1_
- $a Omrani, Ali S $u Hamad Medical Corporation, Doha, Qatar
- 700 1_
- $a Bergantim, Rui $u Centro Hospitalar e Universitário São João, Porto, Portugal
- 700 1_
- $a De Jonge, Nick $u Amsterdam UMC, Location VUmc, Amsterdam, Netherlands
- 700 1_
- $a Fouquet, Guillemette $u Department of Hematology, CH Sud Francilien, Corbeil Essonnes, France
- 700 1_
- $a Navrátil, Milan $u University Hospital Ostrava, Ostrava, Czech Republic
- 700 1_
- $a Abu-Zeinah, Ghaith $u Weill Cornell Medicine, New York, United States
- 700 1_
- $a Samarkos, Michail $u Laikon Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece
- 700 1_
- $a Maertens, Johan $u KU Leuven, Leuven, Belgium
- 700 1_
- $a De Ramón, Cristina $u Hospital Universitario de Salamanca, Salamanca, Spain
- 700 1_
- $a Guidetti, Anna $u University of Milan and Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy
- 700 1_
- $a Magyari, Ferenc $u Division of Hematology, Department of Internal Medicine, University of Debrecen, Debrecen, Hungary
- 700 1_
- $a González-López, Tomás José $u Department of Hematology, Hospital Universitario de Burgos, Burgos, Spain
- 700 1_
- $a Lahmer, Tobias $u Medizinische Klinik II, Klinikum Rechts der Isar, TU München, Munich, Germany
- 700 1_
- $a Finizio, Olimpia $u UOC Hematology, AORN Cardarelli, Naples, Italy
- 700 1_
- $a Ali, Natasha $u Aga Khan University, Karachi, Pakistan
- 700 1_
- $a Pinczés, László Imre $u Division of Hematology, Department of Internal Medicine, University of Debrecen, Debrecen, Hungary
- 700 1_
- $a Lavilla-Rubira, Esperanza $u Hospital Universitario Lucus Augusti, Lugo, Spain
- 700 1_
- $a Romano, Alessandra $u AOU Policlinico Rodolico San Marco, Catania, Italy
- 700 1_
- $a Merelli, Maria $u Azienda Sanitaria Universitaria del Friuli Centrale, Udine, Italy
- 700 1_
- $a Delia, Mario $u Hematology and Stem Cell Transplantation Unit, AOUC Policlinico, Bari, Italy
- 700 1_
- $a Calbacho, Maria $u Hospital Universitario 12 de Octubre, Madrid, Spain
- 700 1_
- $a Meletiadis, Joseph $u Clinical Microbiology Laboratory, Medical School, "Attikon" University General Hospital, National and Kapodistrian University of Athens, Athens, Greece
- 700 1_
- $a Antić, Darko $u University Clinical Center of Serbia, Belgrade, Serbia
- 700 1_
- $a Hernández-Rivas, José-Ángel $u Hospital Universitario Infanta Leonor, Madrid, Spain
- 700 1_
- $a Marques de Almeida, Joyce $u Istituto Oncologico della Svizzera Italiana, Bellinzona, Switzerland
- 700 1_
- $a Al-Khabori, Murtadha $u Sultan Qaboos University Hospital, Muscat, Oman
- 700 1_
- $a Hoenigl, Martin $u Division of Infectious Diseases, ECMM Excellence Center for Clinical Mycology, Department of Internal Medicine, Medical University of Graz, Austria $u BioTechMed, Graz, Austria
- 700 1_
- $a Tisi, Maria Chiara $u San Bortolo Hospital, Vicenza, Italy
- 700 1_
- $a Khanna, Nina $u University Hospital of Basel, Basel, Switzerland
- 700 1_
- $a Barać, Aleksandra $u University Clinical Center of Serbia, Belgrade, Serbia
- 700 1_
- $a Eisa, Noha $u Aseer Central Hospital, Abha, Saudi Arabia $u Oncology Center Mansoura University, Mansoura, Egypt
- 700 1_
- $a Di Blasi, Roberta $u Hopital Saint Louis, Paris, France
- 700 1_
- $a Liévin, Raphaël $u Hopital Saint Louis, Paris, France
- 700 1_
- $a Miranda-Castillo, Carolina $u Hospital Rey Juan Carlos, Móstoles, Spain
- 700 1_
- $a Bahr, Nathan C $u University of Kansas Medical Center, Kansas City, United States
- 700 1_
- $a Lamure, Sylvain $u Department of Clinical Hematology, Montpellier University Hospital, IGMM UMR5535 CNRS, University of Montpellier, Montpellier, France
- 700 1_
- $a Papa, Mario Virgilio $u Azienda Ospedaliera Sant'Anna e San Sebastiano, Caserta, Italy
- 700 1_
- $a Yahya, Ayel $u Aseer Central Hospital, Abha, Saudi Arabia
- 700 1_
- $a Aujayeb, Avinash $u Northumbria Healthcare, Newcastle, United Kingdom
- 700 1_
- $a Novák, Jan $u University Hospital of Královské Vinohrady, Prague, Czech Republic
- 700 1_
- $a Erben, Nurettin $u Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine Eskisehir Osmangazi University, Eskisehir, Turkey
- 700 1_
- $a Fernández-Galán, María $u Hospital Universitario Virgen del Puerto, Plasencia, Spain
- 700 1_
- $a Ribera-Santa Susana, José-María $u Clinical Hematology Department, ICO-Hospital Germans Trias i Pujol, Josep Carreras Research Institute, Badalona, Spain
- 700 1_
- $a Rinaldi, Ikhwan $u Cipto Mangunkusumo General Hospital, Jakarta, Indonesia
- 700 1_
- $a Fazzi, Rita $u Hematology and Stem Cell Transplant Unit, Osperadiela University Pisana Company, Pisa, Italy
- 700 1_
- $a Piedimonte, Monica $u "Sapienza" University of Rome, Rome, Italy
- 700 1_
- $a Duléry, Rémy $u Service d'Hématologie Clinique et de Thérapie Cellulaire, Hôpital Saint Antoine, Assistance Publique-Hôpitaux de Paris, Sorbonne Université, Inserm UMRs 938, Paris, France
- 700 1_
- $a Gonzaga, Yung $u Instituto Nacional do Cancer, Rio de Janeiro, Brazil
- 700 1_
- $a Soto-Silva, Andrés $u Faculty of Medicine, University of Chile. Infectious Diseases Unity, Salvador Hospital of Santiago, Santiago de Chile, Chile
- 700 1_
- $a Sapienza, Giuseppe $u Azienda Ospedaliera "Ospedali Riuniti Villa Sofia-Cervello", Palermo, Italy
- 700 1_
- $a Serris, Alexandra $u Necker-Enfants Malades Hospitals, Paris, France
- 700 1_
- $a Drgoňa, Ľuboš $u Comenius University and National Cancer Institute, Bratislava, Slovakia
- 700 1_
- $a Groh, Ana $u Universitätsklinikum Frankfurt am Main, Frankfurt am Main, Germany
- 700 1_
- $a Serrano, Laura $u Hospital Universitario de Cabueñes, Gijón, Spain
- 700 1_
- $a Gavriilaki, Eleni $u General Hospital of Thessaloniki "George Papanikolaou", Thessaloniki, Greece
- 700 1_
- $a Tragiannidis, Athanasios $u General Hospital of Thessaloniki "George Papanikolaou", Thessaloniki, Greece
- 700 1_
- $a Prattes, Juergen $u Medical University of Graz, Graz, Austria
- 700 1_
- $a Coppola, Nicola $u Department of Mental Health and Public Medicine, University of Campania, Naples, Italy
- 700 1_
- $a Otašević, Vladimir $u University Clinical Center of Serbia, Belgrade, Serbia
- 700 1_
- $a Mladenović, Miloš $u COVID Hospital "Batajnica", Belgrade, Serbia
- 700 1_
- $a Mitrović, Mirjana $u University Clinical Center of Serbia, Belgrade, Serbia
- 700 1_
- $a Mišković, Bojana $u Center for Radiology, University Clinical Center of Serbia, Belgrade, Serbia
- 700 1_
- $a Jindra, Pavel $u University Hospital Pilsen, Pilsen, Czech Republic
- 700 1_
- $a Zompi, Sofia $u Stem Cell Transplant Center, AOU Citta' della Salute e della Scienza, Turin, Italy
- 700 1_
- $a Sacchi, Maria Vittoria $u Hematology and Transplant Unit, Azienda Ospedaliera SS Antonio e Biagio e Cesare Arrigo, Alessandria, Italy
- 700 1_
- $a Krekeler, Carolin $u Department of Medicine A for Hematology, Oncology and Pneumology, University Hospital Münster, Münster, Germany
- 700 1_
- $a Infante, Maria Stefania $u Hospital Universitario Infanta Leonor, Madrid, Spain
- 700 1_
- $a García-Bordallo, Daniel $u Hospital Universitario Lucus Augusti, Lugo, Spain
- 700 1_
- $a Çolak, Gökçe Melis $u Department of Infectious Diseases and Clinical Microbiology, School of Medicine, Marmara University, Istanbul, Turkey
- 700 1_
- $a Mayer, Jiří $u Masaryk University and University Hospital Brno - Department of Internal Medicine, Hematology and Oncology, Brno, Czech Republic
- 700 1_
- $a Nygaard, Marietta $u Zealand University Hospital, Roskilde, Denmark
- 700 1_
- $a Hanáková, Michaela $u Institute of Hematology and Blood Transfusion, Prague, Czech Republic $u Department of Physiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic
- 700 1_
- $a Ráčil, Zdeněk $u Institute of Hematology and Blood Transfusion, Prague, Czech Republic $u Department of Physiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic
- 700 1_
- $a Bonanni, Matteo $u Hematology Unit, Fondazione Policlinico Universitario Agostino Gemelli - IRCCS, Rome, Italy $u Hematology Unit, Università Cattolica del Sacro Cuore, Rome, Italy
- 700 1_
- $a Koehler, Philipp $u University of Cologne, Faculty of Medicine, and University Hospital Cologne, Institute of Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, Germany $u University of Cologne, Faculty of Medicine, University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) and Excellence Center for Medical Mycology (ECMM), Cologne, Germany
- 700 1_
- $a Rahimli, Laman $u University of Cologne, Faculty of Medicine, and University Hospital Cologne, Institute of Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, Germany $u University of Cologne, Faculty of Medicine, University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) and Excellence Center for Medical Mycology (ECMM), Cologne, Germany
- 700 1_
- $a Cornely, Oliver A $u University of Cologne, Faculty of Medicine, and University Hospital Cologne, Institute of Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, Germany $u University of Cologne, Faculty of Medicine, University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) and Excellence Center for Medical Mycology (ECMM), Cologne, Germany $u German Centre for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany $u University of Cologne, Faculty of Medicine and University Hospital Cologne, Clinical Trials Centre Cologne (ZKS Köln), Cologne, Germany
- 700 1_
- $a Pagano, Livio $u Hematology Unit, Fondazione Policlinico Universitario Agostino Gemelli - IRCCS, Rome, Italy $u Hematology Unit, Università Cattolica del Sacro Cuore, Rome, Italy
- 710 2_
- $a EPICOVIDEHA registry
- 773 0_
- $w MED00200566 $t EClinicalMedicine $x 2589-5370 $g Roč. 71 (20240318), s. 102553
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/38533127 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20240405 $b ABA008
- 991 __
- $a 20240412130947 $b ABA008
- 999 __
- $a ok $b bmc $g 2075937 $s 1215265
- BAS __
- $a 3
- BAS __
- $a PreBMC-PubMed-not-MEDLINE
- BMC __
- $a 2024 $b 71 $c - $d 102553 $e 20240318 $i 2589-5370 $m EClinicalMedicine $n EClinicalMedicine $x MED00200566
- LZP __
- $a Pubmed-20240405
